Verified peer comparison
Koss vs Cadrenal Therapeutics Financial Comparison
Direct answer
Koss and Cadrenal Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Koss email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Koss Revenue
- 12,624,170 USD
- Cadrenal Therapeutics Revenue
- 0 USD
- Koss Operating income
- -1,737,123 USD
- Cadrenal Therapeutics Operating income
- -13,461,177 USD